Test CINtec Plus Cytology

What is the CINtec® Plus test?

The test is used to detect cancerous lesions caused by the high-oncogenic human papillomavirus in the early stages of cancer development. As a result of human papilloma virus (HPV) infection, the cellric cycle is disrupted. The test is performed on a liquid cytological medium. In the laboratory, the smear slide is subjected to a special procedure, whichra consists in appropriate staining of the cellsrek. Thanks to this, two biomarkers, p16 and Ki-67, are detected, which makes it possible to locate cellsrs that do not divide in a normal mannerb.

Who should take the CINtec® PLUS test?

The CINtec® PLUS test is intended for patients whor who:

• gynecologic cytology showed ASCUS, LSIL lesions
• with a normal cytology result, a positive test result for HPV was obtained
• no definite diagnosis can be made by cytology

The test should be ordered for clinical indications based on a physician's referral. In order to maintain the fullest interpretation of the CINtec® PLUS result, a sequence of tests is recommended

Benefits of performing the CINtec® PLUS test

• enables evaluation of the cellsrek at a very early stage of cancerous lesions
• less invasive and painless examination
• increased diagnostic capabilities
• minimization of abnormal or undiagnostic results
• saving time and cost– no need to repeat cytology
• reducing the likelihood of needing a colposcopic examination

Interpretation oftest results should be conducted by the physician based on the patient's clinical condition, therapies used, and diagnostic test results.